Showing results (451-460 of 1,751) with videos related to
Sort By:
Pageof 176
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 8, 2001
Meta-analysis of adjuvant immunochemotherapy using OK-432 in patients with resected non-small-cell lung cancerJ Sakamoto, S Teramukai, Y Watanabe, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 8, 2001
Sequential administration of interferon-gamma, GM-CSF, and interleukin-2 in patients with metastatic renal cell carcinoma: results of a phase II trialM Schmidinger, G Steger, C Wenzel, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 5, 2000
Long-term survival of anti-tumor lymphocytes generated by vaccination of patients with melanoma with a peptide vaccineJ H Stewart, S A RosenbergJournal of Immunotherapy (Hagerstown, Md. : 1997)|August 5, 2000
Intracranial paracrine interleukin-2 therapy stimulates prolonged antitumor immunity that extends outside the central nervous systemM G Ewend, R C Thompson, R Anderson, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 5, 2000
Anti-tumor activity of K1-LysPE38QQR, an immunotoxin targeting mesothelin, a cell-surface antigen overexpressed in ovarian cancer and malignant mesotheliomaR Hassan, J L Viner, Q C Wang, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 5, 2000
Augmentation of 17-1A-induced antibody-dependent cellular cytotoxicity by the triple cytokine combination of interferon-alpha, interleukin-2, and interleukin-12D Flieger, U Spengler, I Beier, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 5, 2000
Phase 1 study in patients with metastatic melanoma of immunization with dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp100M C Panelli, J Wunderlich, J Jeffries, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 5, 2002
Immune response against 3LL Lewis lung carcinoma potentiates the therapeutic efficacy of endostatinM Li, X Huang, Z Zhu, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 5, 2002
Interactions between dendritic cells and cytokine-induced killer cells lead to an activation of both populationsA Märten, C Ziske, B Schöttker, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 22, 2001
Adenovirus-Mediated MUC1 gene transduction into human blood-derived dendritic cellsK Maruyama, Y Akiyama, N Nara-Ashizawa, et al.Pageof 176